Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Cetirizine impurity 7 hydrochloride is a known impurity of Cetirizine hydrochloride, primarily studied in the context of pharmaceutical quality control. This compound is relevant for research examining the stability and purity of Cetirizine formulations, as well as for compliance with regulatory standards. Its analysis is critical for ensuring the safety and efficacy of Cetirizine-based therapies. -
Drug Impurity
Methylprednisolone acetate impurity 9, also known as 6alpha-Methyl Prednisone 21-Acetate, serves as a significant impurity of Methylprednisolone acetate. This compound can be utilized for quality control and analytical assessment in pharmaceutical research and development settings. Understanding its profile is essential for ensuring the purity and efficacy of corticosteroid formulations. -
Drug Impurity
Simvastatin impurity 1 is a known impurity associated with the cholesterol-lowering agent Simvastatin. This compound is important for quality control and analytical studies in pharmaceutical development, ensuring the purity and efficacy of Simvastatin formulations. Researchers use this impurity in method validation and stability testing to assess the impact of impurities on pharmacological activity. -
Drug Impurity
Metoprolol impurity 14 is a known impurity associated with the beta-1 adrenergic antagonist Metoprolol. This compound serves as a critical reference standard for the analysis and characterization of drug formulations, particularly in the context of pharmaceutical quality control and stability testing. Its identification and quantification are essential in ensuring drug purity and compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Ibuprofen impurity 10 is a specific impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen. It is utilized primarily in pharmaceutical research for quality control and analytical assessments of ibuprofen formulations. Understanding this impurity's characteristics is essential for ensuring the safety and efficacy of ibuprofen-containing medicines. -
Drug Impurity
Telmisartan impurity 18, also known as Telmisartan tert-Butyl Ester, is a chemical impurity associated with the synthesis of Telmisartan. This compound is relevant for analytical and quality control purposes in pharmaceutical research, particularly for assessing the purity of Telmisartan formulations. Its presence may impact the pharmacological profile and safety assessment of the final product, making it significant in drug development and regulatory compliance studies. -
Drug Impurity
Azithromycin impurity 22, also known as Azithromycin N-Ethyl, is a notable impurity associated with the antibiotic Azithromycin. This compound is essential for quality control and analytical studies in pharmaceutical research, primarily focusing on drug formulation and stability. Its characterization aids in the evaluation of the purity and efficacy of Azithromycin formulations. -
Drug Impurity
3-Chloropropanoic acid 6-(4-hydroxyphenoxy)hexyl ester is a chemical compound that serves as a drug impurity. This reagent is important for the evaluation of drug formulations and can provide insights into the stability and purity of pharmaceutical products. Its characterization is essential for quality control and regulatory compliance in drug development processes. -
Drug Impurity
Dexamethasone impurity 6 is a known impurity associated with the corticosteroid Dexamethasone. This compound is relevant in evaluating the purity and quality of Dexamethasone formulations. It plays a crucial role in pharmaceutical research and development, particularly in ensuring compliance with regulatory standards for drug substances. -
Drug Impurity
Furosemide impurity 1, also known as Isofurosemide, serves as a notable impurity associated with Furosemide. This compound is primarily utilized in the assessment of drug purity and quality control in pharmaceutical development. Its presence can be critical for understanding degradation pathways and ensuring product safety in formulations containing Furosemide. -
Drug Impurity
Famotidine impurity 4 is a minor impurity of the antihistamine Famotidine, primarily identified during the synthesis and analysis of the compound. This reagent serves as a critical reference standard for quality control and analytical research, enabling the accurate assessment of drug purity and efficacy. The presence of this impurity can aid in studies related to drug metabolism and pharmacokinetics. -
Drug Impurity
Omeprazole impurity 6 is a known impurity associated with Omeprazole, a proton pump inhibitor used in the treatment of gastroesophageal reflux disease (GERD). This compound may serve as a reference standard in quality control and stability studies for pharmaceutical formulations containing Omeprazole. Its characterization is crucial for ensuring compliance with regulatory standards and for understanding the implications of impurities on drug efficacy and safety. -
Drug Impurity
Clindamycin palmitate impurity 1, also known as Clindamycin heptadecanoate, is classified as a drug impurity. It is often encountered during the synthesis and analysis of Clindamycin formulations. This compound serves as a valuable analytical standard, aiding in the assessment of drug purity and safety in pharmaceutical research. Its presence is critical for understanding the degradation pathways and overall stability of clindamycin-based therapeutics. -
Drug Impurity
Estradiol Valerate impurity 6 is a known impurity associated with Estradiol Valerate. This chemical compound serves as a valuable reference standard in the quality control and development of pharmaceutical formulations. Its identification and quantification are essential for ensuring the purity and safety of estradiol-based therapeutics in research applications. -
Drug Impurity
Sertraline impurity 2 hydrochloride is a chemical impurity associated with Sertraline hydrochloride. This compound is primarily utilized in the assessment of pharmaceutical quality and stability, serving as a reference standard in analytical chemistry. Its presence is critical for ensuring consistent drug formulations and facilitating compliance with regulatory guidelines in pharmaceutical research. -
Drug Impurity
Salbutamol impurity 11, also known as 4-Benzyl Albuterol, is a known impurity of the beta-adrenergic agonist Salbutamol. This compound can be used in analytical chemistry for quality control and validation of Salbutamol formulations. Its biological activity may contribute to understanding the metabolism and degradation pathways of Salbutamol in various biological systems. -
Drug Impurity
Trityl candesartan cilexetil is a minor drug impurity of candesartan cilexetil, an angiotensin II receptor antagonist. This compound may be utilized for analytical and quality control purposes in pharmaceutical research, especially in studies assessing the purity and stability of candesartan formulations. Its role as a reference standard in method development and validation makes it significant for ensuring the integrity of pharmaceutical products. -
Drug Impurity
Paliperidone impurity 8 hydrochloride is a drug impurity associated with paliperidone hydrochloride. This compound is primarily used for quality control in pharmaceutical research and development, particularly in the analysis and characterization of antipsychotic medications. Its presence can affect the efficacy and safety profiles of the parent compound, making it essential for evaluating metabolic pathways and ensuring pharmaceutical compliance. -
Drug Impurity
Tamsulosin impurity 13 is a pharmaceutical impurity associated with Tamsulosin. This compound is utilized primarily for analytical research, particularly in assessing the purity of Tamsulosin in pharmaceutical formulations. It serves as a reference standard for stability studies and quality control, aiding in the compliance with regulatory guidelines for drug development. -
Drug Impurity
Ropinirole impurity 11 is identified as a chemical impurity associated with the synthesis of Ropinirole. This compound is utilized primarily in quality control and analytical chemistry to assess the purity of Ropinirole formulations. It serves as a reference standard for researchers investigating the implications of impurities in pharmaceutical development and safety studies. -
Drug Impurity
Famotidine impurity 9, also known as Famotidine cyanoamidine, is a drug impurity associated with Famotidine. This compound is of significant interest for researchers monitoring the quality and integrity of pharmaceutical formulations. Its characterization supports studies evaluating the stability and safety profiles of Famotidine-based therapies. -
Drug Impurity
Bupropion impurity 19 is a known impurity of the antidepressant Bupropion. As a chemical research reagent, it serves as an important tool for analytical and developmental studies in pharmaceutical research. Its presence and characterization are essential for ensuring the quality and safety of Bupropion formulations, contributing to the understanding of drug metabolism and formulation integrity. -
Drug Impurity
Esomeprazole impurity 1 is a known impurity of the proton pump inhibitor Esomeprazole, primarily affecting gastric acid secretion. This compound serves as a crucial reference standard for analytical and quality control studies, facilitating the assessment of Esomeprazole purity and stability in pharmaceutical formulations. It is relevant in pharmacokinetic studies and method development for detecting impurities in drug substances. -
Drug Impurity
Rebamipide impurity 5 is a chemical impurity related to the pharmaceutical compound Rebamipide. This impurity is primarily utilized in the analysis and quality control of Rebamipide formulations. Research applications include method development for impurity profiling and assessing the stability and purity of drug substances in pharmaceutical studies. -
Drug Impurity
Beclometasone dipropionate impurity 6, also known as Beclomethasone 11,17,21-tripropionate, is a drug impurity related to Beclometasone dipropionate. This compound serves as a critical marker in assessing the purity of Beclometasone dipropionate in pharmaceutical formulations. Its identification and quantification are essential for quality control and regulatory compliance in drug development and manufacturing processes. -
Drug Impurity
Aripiprazole impurity 29 is a synthetic byproduct of Aripiprazole, a medication primarily utilized in the treatment of schizophrenia and bipolar disorder. This reagent serves as a reference standard for analytical methods aimed at assessing the purity of Aripiprazole formulations. Its role in drug development and quality control ensures compliance with pharmaceutical regulations. -
Drug Impurity
Rivaroxaban impurity 15 is a characterized impurity associated with the anticoagulant Rivaroxaban. This compound is crucial for quality control and validation in pharmaceutical research and development, enabling scientists to understand its effects on drug stability and efficacy. It serves as a reference standard in analytical chemistry for assessing the purity of Rivaroxaban formulations in compliance with regulatory standards. -
Drug Impurity
Rivaroxaban impurity 25 is a known impurity associated with the anticoagulant Rivaroxaban. It is primarily utilized in analytical and quality control settings for the assessment of drug purity and stability. The characterization of this impurity is essential for ensuring compliance with regulatory standards and understanding the compound's overall pharmacological profile. -
Drug Intermediate
Mesalazine impurity 7 is a drug intermediate associated with the synthesis of Mesalazine. It serves as a valuable reference standard for analytical applications such as purity assessment and method development in pharmaceutical research. Understanding impurities like Mesalazine impurity 7 is essential for ensuring the quality and safety of Mesalazine-containing formulations. -
Drug Impurity
Methylprednisolone impurity 7 is a known impurity of the corticosteroid Methylprednisolone. This compound is utilized primarily in the pharmaceutical industry for stability testing and quality control assessments. Its identification and quantification are crucial for ensuring the purity and safety of corticosteroid preparations in clinical applications and research. -
Drug Impurity
Candesartan impurity 19 is a characterized impurity associated with the angiotensin II receptor blocker, Candesartan. This compound is utilized for analytical and quality control purposes in pharmaceutical research to ensure the purity and safety of Candesartan formulations. Its presence can impact the overall pharmacological profile of drug products, making it significant for studies focused on drug formulation and regulatory compliance. -
Drug Impurity
Quetiapine impurity 9, identified as a specific drug impurity of Quetiapine, serves as an essential reference standard in pharmaceutical research. Its analysis is critical for assessing the purity and quality of Quetiapine formulations. This impurity aids in the development of reliable analytical methods and ensures compliance with regulatory requirements in drug manufacturing and safety evaluation. -
Oseltamivir Impurity
4-N-Desacetyl-5-N-acetyl oseltamivir is an impurity of Oseltamivir, a neuraminidase inhibitor primarily used in the treatment of influenza. This compound can be utilized in quality control and analytical studies related to the synthesis and stability of Oseltamivir. Its identification and characterization are essential for ensuring the purity and efficacy of antiviral formulations. -
Drug Impurity
Palbociclib impurity 20 is a known impurity of the CDK4/6 inhibitor palbociclib, a key compound in the treatment of various cancers. This reagent is essential for quality control and stability studies in pharmaceuticals, enabling researchers to evaluate the purity and safety of drug formulations. Its analysis is crucial in ensuring compliance with regulatory standards in the development of palbociclib-based therapies. -
Drug Impurity
Estradiol Valerate impurity 1 is a known impurity associated with the synthetic steroid hormone Estradiol Valerate. Its characterization is essential in assessing the purity and quality of pharmaceutical preparations containing Estradiol Valerate. This compound can be utilized in analytical chemistry, particularly in method development and validation for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Levothyroxine impurity 2 is a recognized impurity associated with levothyroxine, a synthetic form of the thyroid hormone thyroxine. This compound serves as a reference standard for quality control and analytical studies in pharmaceutical development. Researchers utilize this impurity to ensure the purity and efficacy of levothyroxine formulations in compliance with regulatory standards. -
Drug Impurity
Alfuzosin EP impurity 5 is a chemical impurity associated with Alfuzosin EP, a medication primarily used as an alpha-1 adrenergic antagonist. This compound is essential for quality control and analytical studies in pharmaceutical research. It serves as a reference standard for assessing the purity of Alfuzosin EP during drug formulation and stability testing. -
Drug Impurity
Pantoprazole impurity 5 (N1-Methyl pantoprazole) is a known impurity of the proton pump inhibitor Pantoprazole. This compound may be utilized in analytical studies to assess the quality and stability of Pantoprazole formulations. Research applications include impurity profiling and evaluation of pharmaceutical manufacturing processes. -
Drug Impurity
Fusidic acid impurity 8 is a byproduct associated with the synthesis of Fusidic acid. This compound serves as a valuable reference standard for analytical methodologies aimed at assessing the purity and quality of Fusidic acid formulations. Its presence can impact pharmacological properties and is relevant for regulatory compliance in drug development and quality control processes. -
Drug Impurity
Tazobactam impurity 13 is a chemical impurity associated with Tazobactam, a β-lactamase inhibitor. This compound can be utilized in the characterization and quality control of Tazobactam formulations, thereby supporting analytical research and regulatory compliance in pharmaceutical development. Its identification is crucial for ensuring the purity and safety of drug products containing Tazobactam. -
Drug Impurity
Escitalopram impurity 4 is a known impurity of the selective serotonin reuptake inhibitor (SSRI) escitalopram. Its presence can be significant in the assessment of drug quality and safety, particularly in pharmacokinetic studies. This reagent may be used in research focused on drug formulation, stability testing, and analytical chemistry to ensure compliance with regulatory standards. -
Drug Impurity
Betamethasone impurity 3 is a recognized impurity of the corticosteroid drug Betamethasone. As a compound, it serves as a useful reference standard in analytical chemistry and quality control processes to evaluate the purity of Betamethasone formulations. Researchers employ this impurity in various studies focusing on drug stability, efficacy, and safety assessments within pharmaceutical development. -
Drug Impurity
Donepezil impurity 9, also known as Donepezil impurity G, is a drug impurity associated with the synthesis of Donepezil. This compound is utilized in quality control and stability studies of Donepezil formulations. Research applications include the assessment of purity and identification of synthetic by-products, which are essential for ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Mesalazine impurity 10 (N-Propionyl Mesalazine) is a known impurity of the anti-inflammatory drug Mesalazine. This compound may be utilized in drug development and quality control to assess the purity and safety of Mesalazine formulations. Its presence can impact the efficacy and side effect profile of pharmaceutical preparations, making it relevant for analytical and regulatory assessments in pharmaceutical research. -
Drug Impurity
Mirabegron impurity 12 is a known impurity associated with the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. This impurity may be important for analytical characterization and quality control in pharmaceutical research and development. Its detection and quantification can aid in understanding the safety and efficacy profiles of Mirabegron formulations. -
Drug Impurity
Olmesartan impurity 4 is a specified impurity associated with Olmesartan, an angiotensin II receptor antagonist used primarily for the treatment of hypertension. This impurity can serve as an important analytical standard in pharmaceutical research and development, aiding in the assessment of drug purity and quality control. Its analysis is essential for ensuring compliance with regulatory standards and for understanding the implications of impurities on drug efficacy and safety. -
Drug Impurity
Rosuvastatin impurity 38 calcium is a known impurity associated with Rosuvastatin calcium, a medication commonly used to lower cholesterol levels. This compound serves as a reference standard for the identification and quantification of impurities during pharmaceutical analysis. Its biological activity may offer insights into the safety and efficacy profiles of Rosuvastatin formulations in research applications. -
Drug Impurity
Ketoconazole impurity 5 is a known impurity of the antifungal agent ketoconazole. This compound is utilized in analytical chemistry to assess the purity and quality of pharmaceutical formulations containing ketoconazole. It serves as a crucial reference standard for ensuring compliance with regulatory guidelines in drug development and quality control. -
Drug Impurity
Azilsartan impurity 32 is a chemical impurity associated with Azilsartan, an antihypertensive agent that primarily targets the angiotensin II receptor. This impurity is relevant for analytical and quality control applications in the pharmaceutical industry, facilitating the assessment of drug purity and compliance with regulatory standards. It is essential for researchers conducting stability studies and formulation development involving Azilsartan. -
Drug Impurity
Meloxicam impurity 6 is a characterized impurity of the non-steroidal anti-inflammatory drug Meloxicam. It serves as a valuable reference standard for quality control and method development in pharmaceutical analysis. This impurity is important for understanding the chemical profile of Meloxicam and ensuring the integrity of formulations in drug development studies.
